This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Stanley Lasch
Introduction
Stanley Lasch is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His work focuses on innovative therapies that aim to improve the quality of life for individuals suffering from these conditions.
Latest Patents
Lasch holds a patent for a groundbreaking invention titled "Combination therapy for the treatment of autoimmune diseases." This patent pertains to compounds and their combination for use in the prevention or therapy of subjects suffering from autoimmune diseases, such as type 1 diabetes. The invention provides antagonists of T-cells that are used in combination with antagonists of the cytokine CXCL10, either sequentially or concomitantly, to treat individuals with autoimmune diseases, particularly type 1 diabetes.
Career Highlights
Stanley Lasch is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to explore innovative solutions to complex medical challenges.
Collaborations
Lasch has collaborated with esteemed colleagues, including Michael John Parnham and Urs Christen. These partnerships have fostered a collaborative environment that enhances the development of effective therapies for autoimmune diseases.
Conclusion
Stanley Lasch's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving treatment options for autoimmune diseases. His work continues to inspire advancements in medical research and therapy.